Skip to main content
Clinical Trials/CTRI/2021/12/038700
CTRI/2021/12/038700Not yet recruitingPhase 3

A preand post test for assessment of combined efficacy of sigrusimhyadi nasya and kadali ksharapratisanna in hypertrophic rhinitis

Dr Anjali A0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1.Patients of age 20â?? 60 years
  • 2.Patients satisfying the diagnostic criteria with compensatory turbinate hypertrophy
  • 3.Patients of either sex
  • 4.Patients fit for Nasya karma and Kshara karma

Exclusion Criteria

  • 1.Patients having any previous history of nasal surgery
  • 2.Previous history of allergic rhinitis
  • 3.History of use of nasal decongestion, corticosteroids within 6 months
  • 4.Pregnant and lactating women

Investigators

Sponsor
Dr Anjali A

Similar Trials